![NGS technology has enabled researchers to epidemiologically analyze DNA sequences by quickly deciphering mass quantities of genetic information in a short amount of time. [Heart illustration: iStock/SvetaP DNA double helix: iStock/Kagenmi]](https://www.clinicalomics.com/wp-content/uploads/2019/01/304-218x150.jpeg "Polygenic Risk Scores Predict Heart Disease Across Diverse Populations")
![NGS technology has enabled researchers to epidemiologically analyze DNA sequences by quickly deciphering mass quantities of genetic information in a short amount of time. [Heart illustration: iStock/SvetaP DNA double helix: iStock/Kagenmi]](https://www.clinicalomics.com/wp-content/uploads/2019/01/304-356x220.jpeg "Polygenic Risk Scores Predict Heart Disease Across Diverse Populations")
Foundation Medicine CEO Cindy Perettie’s Top ASCO 2019 Takeaways
By Cindy Perettie, CEO, Foundation Medicine
The way ASCO started for me this year set the scene for what was an inspiring and fascinating weekend....
AMP Adds Conditions to Support of Consumer Genomic Tests
The Association for Molecular Pathology (AMP) said today it has expanded its set of conditions it wants to see met before it will support...
Not if. When: Metabolomics’ Impact in Cancer Treatments May be Just Around the Corner
The possibility of metabolomics playing a role in cancer diagnostics and treat- ment seems, to many metabolomicists, a question of when rather than if....
Genetic Variation Influences Effectiveness of Vaccines
A genome-wide association study GWAS, headed by a team at the University of Oxford, U.K., and involving thousands of children in the U.K. and...
10 Countries in 100K Genome Club
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
20 Molecular Diagnostics Companies to Watch
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
PerkinElmer, Helix Partner to Launch Genetic Screening Test
The DNA test available to healthy individuals analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics.
Clinical Urologists Group Supports Genomic Testing for Prostate Cancer
AACU statement encourages use of tissue-based molecular testing and/or germline testing for three groups of prostate cancer patients
Clinical NGS IDs Pathogens in Brain and Spinal Fluid Missed by Other Tests
Doctors were able to give critically ill patients with mysterious neurological symptoms life-saving treatment thanks to a new clinical application of next-generation sequencing (NGS)....
Mammoth Competition: Feng Zhang, Partners Launch CRISPR Dx Company
Company will leverage synthetic biology and CRISPR patents held by the Broad Institute and Harvard's Wyss Institute to create next-gen MDxes
